Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Technology
History
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/a0/63/55/a06355c1-5204-6df1-4958-46ab0c4064a6/mza_6184543575285791093.jpg/600x600bb.jpg
Development and Research
Ross Rheingans-Yoo
6 episodes
2 days ago
The clinical trials process is broken. It is unbelievably expensive and slow: it takes more than ten years and a billion dollars to get a typical drug approved. Join Ross Rheingans-Yoo on Development & Research—a new video series on fixing drug development, with new episodes on some Tuesdays.
Show more...
Science
RSS
All content for Development and Research is the property of Ross Rheingans-Yoo and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The clinical trials process is broken. It is unbelievably expensive and slow: it takes more than ten years and a billion dollars to get a typical drug approved. Join Ross Rheingans-Yoo on Development & Research—a new video series on fixing drug development, with new episodes on some Tuesdays.
Show more...
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/43602432/43602432-1755717881233-aaf1d9f19a80d.jpg
Drugs that work for everyone — with Mark Dybul
Development and Research
1 hour 2 minutes 40 seconds
2 months ago
Drugs that work for everyone — with Mark Dybul

When the CEO of Walmart explained why his company was partnering with a U.S. global AIDS program, he didn't mention humanitarian concerns. He said Walmart couldn’t make its ten-year growth projections without a healthy, economically growing Africa—because a sick continent disrupted supply chains and eliminated future customers.

I’m joined this week by Ambassador Mark Dybul, one of the architects of the President's Emergency Plan for AIDS Relief, who argues that America has forgotten the core insight of the Marshall Plan: supporting other countries’ economic growth creates markets for American businesses, not competition for American workers.

We talk about drug development, too—why many drugs don’t work in women and people of color, how buying HIV drugs for Africa led to improved treatments for Americans, whether the FDA was wrong to reject MDMA for PTSD, and the changes that could cut drug development expenses by orders of magnitude while producing treatments that actually work for everyone, supporting American geopolitical dominance, and defusing geopolitical instabilities that will “make pandemics looks like child’s play”.

Development and Research
The clinical trials process is broken. It is unbelievably expensive and slow: it takes more than ten years and a billion dollars to get a typical drug approved. Join Ross Rheingans-Yoo on Development & Research—a new video series on fixing drug development, with new episodes on some Tuesdays.